Screener
Chemed CHE Segment Vitas — Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Chemed in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The source filing: Chemed’s 10-Q, filed April 28, 2026.
- Filed
- Apr 28, 2026, 9:00 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000019584-26-000012
| Line item | Medicare | Medicaid | Commercial | Total |
|---|---|---|---|---|
| Continuous care | 16,582 | 551 | 1,000 | 18,133 |
| $398,108 | $15,432 | $11,609 | $425,149 | |
| All other revenue - self-pay, respite care, etc. | 5,578 | |||
| Subtotal | $430,727 | |||
| Medicare cap adjustment | (2,375) | |||
| Implicit price concessions | (5,077) | |||
| Room and board, net | (3,257) | |||
| Net revenue | $420,018 |
Item 1. Financial Statements
FAQ
- What is Chemed's segment vitas — revenue?
- Chemed (CHE) reported segment vitas — revenue of $420.02M in Q1 2026.
- How has Chemed's segment vitas — revenue changed year-over-year?
- Chemed's segment vitas — revenue increased by 3.1% year-over-year, from $407.4M to $420.02M.
- What is the long-term trend for Chemed's segment vitas — revenue?
- Over 2 years (2023 to 2025), Chemed's segment vitas — revenue has grown at a 11.3% compound annual growth rate (CAGR), from $1.32B to $1.63B.
- What does segment vitas — revenue mean?
- The total amount of money generated by the business segment through the provision of services before the deduction of operating expenses. This is the primary measure of the segment's scale and market presence.
Ask your AI about Chemed's segment vitas — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude